Cigna Corporation (NYSE:CI) Director Jane E. Md Henney sold 600 shares of the company’s stock in a transaction dated Monday, July 24th. The shares were sold at an average price of $174.14, for a total transaction of $104,484.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Cigna Corporation (NYSE CI) traded down 0.41% during midday trading on Tuesday, reaching $173.81. 1,166,110 shares of the company traded hands. The stock has a market capitalization of $44.50 billion, a P/E ratio of 23.21 and a beta of 0.46. The firm has a 50-day moving average of $169.58 and a 200-day moving average of $156.35. Cigna Corporation has a 1-year low of $115.03 and a 1-year high of $175.80.

Cigna Corporation (NYSE:CI) last announced its quarterly earnings results on Friday, May 5th. The health services provider reported $2.77 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.44 by $0.33. Cigna Corporation had a return on equity of 16.07% and a net margin of 6.53%. The company had revenue of $10.39 billion during the quarter, compared to the consensus estimate of $10.11 billion. During the same period in the previous year, the company posted $2.46 earnings per share. Cigna Corporation’s revenue for the quarter was up 5.1% on a year-over-year basis. On average, analysts predict that Cigna Corporation will post $9.79 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Cigna Corporation (NYSE:CI) Director Jane E. Md Henney Sells 600 Shares” was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/07/25/cigna-corporation-nyseci-director-jane-e-md-henney-sells-600-shares.html.

Several equities research analysts have recently commented on the stock. Deutsche Bank AG assumed coverage on shares of Cigna Corporation in a research report on Wednesday, April 5th. They set a “buy” rating and a $172.00 price target for the company. CIBC upped their price target on shares of Cigna Corporation from $174.00 to $185.00 and gave the company an “outperform” rating in a research report on Thursday, June 15th. Wells Fargo & Company reaffirmed a “market perform” rating and set a $174.00 price target (up previously from $163.00) on shares of Cigna Corporation in a research report on Monday, June 19th. Oppenheimer Holdings, Inc. upped their price target on shares of Cigna Corporation from $174.00 to $185.00 and gave the company an “outperform” rating in a research report on Thursday, June 15th. Finally, ValuEngine raised shares of Cigna Corporation from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Three analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. Cigna Corporation currently has a consensus rating of “Buy” and a consensus target price of $176.33.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. American Beacon Advisors Inc. bought a new position in shares of Cigna Corporation during the first quarter worth about $102,000. Baystate Wealth Management LLC increased its position in shares of Cigna Corporation by 436.1% in the first quarter. Baystate Wealth Management LLC now owns 772 shares of the health services provider’s stock worth $116,000 after buying an additional 628 shares during the last quarter. Founders Capital Management bought a new position in shares of Cigna Corporation during the first quarter worth about $117,000. Mckinley Capital Management LLC Delaware bought a new position in shares of Cigna Corporation during the first quarter worth about $122,000. Finally, Guardian Life Insurance Co. of America increased its position in shares of Cigna Corporation by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock worth $145,000 after buying an additional 7 shares during the last quarter. 86.85% of the stock is owned by institutional investors.

About Cigna Corporation

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Insider Buying and Selling by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.